Role of Angiotensin and Oxidative Stress in Essential Hypertension
- 1 October 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 34 (4) , 943-949
- https://doi.org/10.1161/01.hyp.34.4.943
Abstract
In this review, we examine the possibility that small increments in angiotensin II are responsible for an increase in blood pressure and maintenance of hypertension through the stimulation of oxidative stress. A low dose of angiotensin II (2 to 10 ng x kg(-1) x min(-1), which does not elicit an immediate pressor response), when given for 7 to 30 days by continuous intravenous infusion, can increase mean arterial pressure by 30 to 40 mm Hg. This slow pressor response to angiotensin is accompanied by the stimulation of oxidative stress, as measured by a significant increase in levels of 8-iso-prostaglandin F(2alpha) (F(2)-isoprostane). Superoxide radicals and nitric oxide can combine chemically to form peroxynitrite, which can then oxidize arachidonic acid to form F(2)-isoprostanes. F(2)-isoprostanes exert potent vasoconstrictor and antinatriuretic effects. Furthermore, angiotensin II can stimulate endothelin production, which also has been shown to stimulate oxidative stress. In this way, a reduction in the concentration of nitric oxide (which is quenched by superoxide) along with the formation of F(2)-isoprostanes and endothelin could potentiate the vasoconstrictor effects of angiotensin II. We hypothesize that these mechanisms, which underlie the development of the slow pressor response to angiotensin II, also participate in the production of hypertension when circulating angiotensin II levels appear normal, as occurs in many cases of essential and renovascular hypertension.Keywords
This publication has 49 references indexed in Scilit:
- Prostaglandin endoperoxide‐dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthaseBritish Journal of Pharmacology, 1999
- Stimulatory Effect of 8-Epi-PGF2α, An F2-Isoprostane, on Endothelin-1 ReleaseJournal of Cardiovascular Pharmacology, 1995
- Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cellsKidney International, 1992
- Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins.Hypertension, 1989
- Adrenaline-Induced Hypertension in RatsJournal of Cardiovascular Pharmacology, 1981
- A SLOWLY DEVELOPING PRESSOR RESPONSE TO SMALL CONCENTRATIONS OF ANGIOTENSIN ITS BEARING ON THE PATHOGENESIS OF CHRONIC RENAL HYPERTENSIONThe Lancet, 1963
- Hypertensin: The Substance Causing Renal HypertensionNature, 1939